A reference range egy a Novocastra protfólióból választott antitest csoport. A patológusok és kutatók részére csoportosított antitestek, amelyek egy-egy alkalmazásban optimális festési teljesítményt nyújtanak.
*Erről a termékről további információt kollégánk tud adni.
*További információ erről a termékünkről kollégánktól érhető el.
| Termék neve |
Termék kódja |
Klón |
|
| Adenomatous Polyposis Coli Protein (APC) |
NCL-APC |
EMM43 |
|
| Adenovirus |
NCL-ADENO |
10/5.1.2 |
|
| Akt (Phosphorylated) |
NCL-L-Akt-Phos |
LP18 |
|
| ALCAM (CD166) |
NCL-CD166 |
MOG/07 |
|
| Alpha-1-Antichymotrypsin |
NCL-A1ACp |
Polyclonal |
|
| Alpha-1-Antitrypsin |
NCL-A1Ap |
Polyclonal |
|
| Alpha-Actinin |
NCL-alpha-ACT |
RBC2/1B6 |
|
| Alpha B Crystallin |
NCL-ABCrys-512 |
G2JF |
|
| Alpha-Catenin |
NCL-A-CAT |
25B1 |
|
| Alpha Fetoprotein |
NCL-AFP |
C3 |
|
| Alpha Fetoprotein |
PA0963 |
C3 |
|
| Alpha-Internexin |
NCL-A-INTER |
2E3 |
|
| Alpha Smooth Muscle Actin (SMA) |
NCL-SMA |
αsm-1 |
|
| Alpha Smooth Muscle Actin (SMA) |
PA0943 |
αsm-1 |
|
| Alpha Smooth Muscle Actin (SMA) |
RTU-SMA |
αsm-1 |
|
| Alpha-Synuclein |
NCL-ASYN |
KM51 |
|
| Alpha-Synuclein |
NCL-L-ASYN |
KM51 |
|
| Amyloid A Component |
NCL-AAC |
mc1 |
|
| Amyloid Precursor Protein |
NCL-APP |
40.10 |
|
| Amyloid Precursor Protein |
NCL-APP-228 |
3G12 |
|
| Amyloid P Protein |
NCL-AMP |
B5 |
|
| ALK (Anaplastic Lymphoma Kinase) (CD246) (p80) |
NCL-ALK |
5A4 |
|
| ALK (Anaplastic Lymphoma Kinase) (CD246) (p80) |
PA0306 |
5A4 |
|
| Anaplastic Lymphoma Kinase (ALK) (CD246) (p80) |
NCL-ALK |
5A4 |
|
| Anaplastic Lymphoma Kinase (ALK) (CD246) (p80) |
PA0306 |
5A4 |
|
| Androgen Receptor |
NCL-AR-2F12 |
2F12 |
|
| Androgen Receptor |
NCL-AR-318 |
AR27 |
|
| APC (Adenomatous Polyposis Coli Protein) |
NCL-APC |
EMM43 |
|
| Apolipoprotein D |
NCL-Apo-D |
36C6 |
|
| Apolipoprotein J (Clusterin) |
NCL-CLUSTERIN |
7D1 |
|
| Apoptosis Protease Activating Factor 1 |
NCL-APAF1 |
Polyclonal |
|
| AP-2 Gamma |
NCL-AP2G |
GIA50 |
|
| Aurora Kinase 2 |
NCL-L-AK2 |
JLM28 |
|
| B Cell Marker (MB2) |
NCL-MB2 |
MB2 |
|
| bcl-2 Oncoprotein |
NCL-bcl-2 |
bcl-2/100/D5 |
|
| bcl-2 Oncoprotein |
NCL-bcl-2-486 |
3.1 |
|
| bcl-2 Oncoprotein |
NCL-L-bcl-2 |
bcl-2/100/D5 |
|
| bcl-2 Oncoprotein |
RTU-bcl-2 |
bcl-2/100/D5 |
|
| Bcl-3 Oncoprotein |
NCL-Bcl-3 |
1E8 |
|
| Bcl-6 Oncoprotein |
NCL-Bcl-6 |
P1F6 |
|
| Bcl-6 Oncoprotein |
NCL-L-Bcl-6-564 |
LN22 |
|
| Bcl-6 Oncoprotein |
PA0204 |
LN22 |
|
| Bcl-10 Oncoprotein |
NCL-Bcl-10 |
DAA22 |
|
| Bcl-w |
NCL-Bcl-w |
6C1 |
|
| bcl-x |
NCL-bcl-x |
NC1 |
|
| Beta-2-Microglobulin |
NCL-B2Mp |
Polyclonal |
|
| Beta Amyloid |
NCL-B-Amyloid |
6F/3D |
|
| Beta-Catenin |
NCL-B-CAT |
17C2 |
|
| Beta-Dystroglycan |
NCL-b-DG |
43DAG1/8D5 |
|
| Blood Coagulation Factor XIIIa (Factor XIIIa) |
NCL-FXIIIa |
E980.1 |
|
| Blood Coagulation Factor XIIIa (Factor XIIIa) |
PA0449 |
E980.1 |
|
| BL-CAM (CD22) |
NCL-CD22-2 |
FPC1 |
|
| BL-CAM (CD22) |
PA0249 |
FPC1 |
|
| BM1 (Myeloid Marker) |
NCL-BM1 |
BM-1 |
|
| BM2 (Myeloid Marker) |
NCL-BM2 |
BM-2 |
|
| B Cell Specific Octamer Binding Protein-1 (BOB-1) |
NCL-L-BOB-1 |
TG14 |
|
| B Cell Specific Octamer Binding Protein-1 (BOB-1) |
PA0558 |
TG14 |
|
| Bone Morphogenetic Protein 4 |
NCL-BMP4 |
3H2 |
|
| Bromodeoxyuridine |
NCL-BrdU |
85-2C8 |
|
| c-erbB-2 Oncoprotein (HER-2) Antibodies |
NCL-c-erbB-2-316 |
5A2 |
|
| c-erbB-2 Oncoprotein (HER-2) Antibodies |
NCL-CB11 |
CB11 |
|
| c-erbB-2 Oncoprotein (HER-2) Antibodies |
NCL-CBE-356 |
10A7 |
|
| c-erbB-2 Oncoprotein (HER-2) Antibodies |
NCL-CBE1 |
CBE1 |
|
| c-erbB-2 Oncoprotein (HER-2) Antibodies |
NCL-L-CB11 |
CB11 |
|
| c-erbB-2 Oncoprotein (HER-2) Antibodies |
RTU-CB11 |
CB11 |
|
| c-erbB-2 Oncoprotein (HER-2) Antibodies |
RTU-CBE-356 |
10A7 |
|
| CA125 (Ovarian Cancer Antigen) |
NCL-CA125 |
Ov185:1 |
|
| CA125 (Ovarian Cancer Antigen) |
NCL-L-CA125 |
Ov185:1 |
|
| CA125 (Ovarian Cancer Antigen) |
PA0539 |
Ov185:1 |
|
| CA125 (Ovarian Cancer Antigen) |
RTU-CA125 |
Ov185:1 |
|
| CA19-9 (Sialyl Lewisa ) |
NCL-CA19-9 |
C241:5:1:4 |
|
| CA19-9 (Sialyl Lewisa ) |
NCL-L-CA19-9 |
C241:5:1:4 |
|
| CA19-9 (Sialyl Lewisa ) |
PA0424 |
C241:5:1:4 |
|
| Calbindin |
NCL-CALBINDIN |
KR6 |
|
| Calcitonin |
NCL-CALp |
Polyclonal |
|
| Calcitonin |
PA0406 |
- |
|
| Calmodulin |
NCL-CALMODULIN |
6312 |
|
| Calpain |
NCL-CALP-11B3 |
Calp3c/11B3 |
|
| Calpain |
NCL-CALP-12A2 |
Calp3c/12A2 |
|
| Calpain |
NCL-CALP-2C4 |
Calp3d/2C4 |
|
| Calponin (Basic) |
NCL-CALPONIN-B |
26A11 |
|
| Calponin (Basic) |
PA0416 |
26A11 |
|
| Calretinin (CAL6) |
NCL-L-CALRET-566 |
CAL6 |
|
| Calretinin (5A5) |
NCL-CALRETININ |
5A5 |
|
| Calretinin (5A5) |
NCL-L-CALRETININ |
5A5 |
|
| Calretinin (5A5) |
PA0346 |
5A5 |
|
| Calretinin (5A5) |
RTU-CALRETININ |
5A5 |
|
| Carbonic Anhydrase IX |
NCL-L-CAIX |
TH22 |
|
| Carboxypeptidase M |
NCL-CPMm |
1C2 |
|
| Carcinoembryonic Antigen (CD66e) |
NCL-CEA-2 |
12-140-10 |
|
| Carcinoembryonic Antigen (CD66e) |
NCL-L-CEA-2 |
12-140-10 |
|
| Carcinoembryonic Antigen (CD66e) |
RTU-CEA-2 |
12-140-10 |
|
| Caspase-2 |
NCL-CASP-2 |
10H2 |
|
| Caspase-3 (CPP32) |
NCL-CPP32 |
JHM62 |
|
| Caspase-8 |
NCL-CASP-8 |
11B6 |
|
| Caspase-9 |
NCL-CASP-9 |
2C9B11 |
|
| Cathepsin B |
NCL-CATH-B |
CB131 |
|
| Cathepsin D |
NCL-CDm |
C5 |
|
| Cathepsin G |
NCL-CATH-G |
19C3 |
|
| Cathepsin L |
NCL-CATH-L |
13C2 |
|
| Caveolin-1 |
NCL-L-Caveolin-1 |
4D6 |
|
| CCK-8 (Cholecystokinin) |
NCL-CCK-8p |
Polyclonal |
|
| CD1a |
NCL-CD1a-220 |
JPM30 |
|
| CD1a |
NCL-CD1a-235 |
MTB1 |
|
| CD1a |
NCL-L-CD1a-235 |
MTB1 |
|
| CD1a |
PA0235 |
MTB1 |
|
| CD1a |
RTU-CD1a-235 |
MTB1 |
|
| CD2 (LFA-2) |
NCL-CD2-271 |
AB75 |
|
| CD2 (LFA-2) |
NCL-L-CD2-271 |
AB75 |
|
| CD2 (LFA-2) |
PA0271 |
11F11 |
|
| CD2 (LFA-2) |
RTU-CD2-271 |
AB75 |
|
| CD4 |
NCL-CD4-1F6 |
1F6 |
|
| CD4 |
NCL-CD4-368 |
4B12 |
|
| CD4 |
NCL-L-CD4-1F6 |
1F6 |
|
| CD4 |
NCL-L-CD4-368 |
4B12 |
|
| CD4 |
PA0368 |
4B12 |
|
| CD4 |
RTU-CD4-1F6 |
1F6 |
|
| CD6 |
NCL-CD6-298 |
23 |
|
| CD7 |
NCL-L-CD7-580 |
LP15 |
|
| CD7 |
PA0266 |
LP15 |
|
| CD8 |
NCL-CD8-295 |
1A5 |
|
| CD8 |
NCL-CD8-4B11 |
4B11 |
|
| CD8 |
NCL-L-CD8-295 |
1A5 |
|
| CD8 |
PA0183 |
4B11 |
|
| CD8 |
RTU-CD8-295 |
1A5 |
|
| CD9 (Motility-Related Protein-1) |
NCL-CD9 |
72F6 |
|
| CD10 |
NCL-CD10-270 |
56C6 |
|
| CD10 |
NCL-L-CD10-270 |
56C6 |
|
| CD10 |
PA0270 |
56C6 |
|
| CD10 |
RTU-CD10-270 |
56C6 |
|
| CD11b (Mac-1) |
NCL-CD11b |
44 |
|
| CD11c |
NCL-L-CD11c-563 |
5D11 |
|
| CD11c |
PA0554 |
5D11 |
|
| CD13 |
NCL-CD13-304 |
38C12 |
|
| CD14 |
NCL-CD14-223 |
7 |
|
| CD14 |
NCL-L-CD14-223 |
7 |
|
| CD15 |
NCL-CD15 |
BY87 |
|
| CD15 |
NCL-L-CD15 |
BY87 |
|
| CD15 |
PA0039 |
BY87 |
|
| CD15 |
RTU-CD15 |
BY87 |
|
| CD16 |
NCL-CD16 |
2H7 |
|
| CD19 |
NCL-CD19-2 |
4G7/2E |
|
| CD19 |
NCL-L-CD19-163 |
BT51E |
|
| CD19 |
PA0843 |
BT51E |
|
| CD21 |
NCL-CD21-2G9 |
2G9 |
|
| CD21 |
NCL-L-CD21-2G9 |
2G9 |
|
| CD21 |
PA0171 |
2G9 |
|
| CD22 (BL-CAM) |
NCL-CD22-2 |
FPC1 |
|
| CD22 (BL-CAM) |
PA0249 |
FPC1 |
|
| CD23 |
NCL-CD23-1B12 |
1B12 |
|
| CD23 |
NCL-L-CD23-1B12 |
1B12 |
|
| CD23 |
PA0169 |
1B12 |
|
| CD23 |
RTU-CD23-1B12 |
1B12 |
|
| CD27 |
NCL-CD27 |
137B4 |
|
| CD29 |
NCL-CD29 |
7F10 |
|
| CD30 |
NCL-CD30 |
1G12 |
|
| CD30 |
NCL-CD30-365 |
15B3 |
|
| CD30 |
NCL-L-CD30 |
1G12 |
|
| CD30 |
NCL-L-CD30-591 |
JCM182 |
|
| CD30 |
PA0153 |
1G12 |
|
| CD30 |
RTU-CD30 |
1G12 |
|
| CD31 (PECAM-1) |
NCL-CD31-1A10 |
1A10 |
|
| CD31 (PECAM-1) |
PA0250 |
1A10 |
|
| CD33 |
NCL-L-CD33 |
PWS44 |
|
| CD33 |
PA0555 |
PWS44 |
|
| CD34 (Endothelial Cell Marker) |
NCL-END |
QBEnd/10 |
|
| CD34 (Endothelial Cell Marker) |
NCL-L-END |
QBEnd/10 |
|
| CD34 (Endothelial Cell Marker) |
PA0212 |
QBEnd/10 |
|
| CD34 (Endothelial Cell Marker) |
RTU-END |
QBEnd/10 |
|
| CD35 |
NCL-CD35 |
RLB25 |
|
| CD37 |
NCL-CD37 |
CT1 |
|
| CD38 |
NCL-CD38-290 |
SPC32 |
|
| CD38 |
NCL-L-CD38-290 |
SPC32 |
|
| CD39 |
NCL-CD39 |
22A9 |
|
| CD40 |
NCL-CD40 |
11E9 |
|
| CD41 (GPIIb/IIIa) |
NCL-CD41 |
M148 |
|
| CD42b (GPIb) |
NCL-CD42b |
MM2/174 |
|
| CD43 |
NCL-DFT1 |
DFT1 |
|
| CD43 |
NCL-L-MT1 |
MT1 |
|
| CD43 |
NCL-MT1 |
MT1 |
|
| CD43 |
PA0938 |
MT1 |
|
| CD43 |
RTU-MT1 |
MT1 |
|
| CD44 Variant Antibodies |
NCL-CD44v3 |
VFF-327v3 |
|
| CD44 Variant Antibodies |
NCL-CD44v5 |
VFF-8 |
|
| CD44 Variant Antibodies |
NCL-CD44v6 |
VFF-7 |
|
| CD45RA |
NCL-B1 |
X148 |
|
| CD45RB |
NCL-CD45RB |
MEM55 |
|
| CD45RO |
NCL-L-UCHL1 |
UCHL1 |
|
| CD45RO |
NCL-UCHL1 |
UCHL1 |
|
| CD45RO |
PA0146 |
UCHL1 |
|
| CD45RO |
RTU-UCHL1 |
UCHL1 |
|
| CD45 |
NCL-L-LCA-RP |
RP2/18, RP2/22 |
|
| CD45 |
NCL-LCA |
X16/99 |
|
| CD45 |
NCL-LCA-RP |
RP2/18, RP2/22 |
|
| CD45 |
PA0042 |
X16/99 |
|
| CD45 |
RTU-LCA-RP |
RP2/18, RP2/22 |
|
| CD49b (VLA-2) |
NCL-CD49b |
AK7 |
|
| CD49c (VLA-3) |
NCL-CD49c |
VM-2 |
|
| CD54 (ICAM-1) |
NCL-CD54-307 |
23G12 |
|
| CD56 (NCAM) |
NCL-CD56-1B6 |
1B6 |
|
| CD56 (NCAM) |
NCL-CD56-504 |
CD564 |
|
| CD56 (NCAM) |
NCL-L-CD56-1B6 |
1B6 |
|
| CD56 (NCAM) |
PA0191 |
CD564 |
|
| CD56 (NCAM) |
RTU-CD56-1B6 |
1B6 |
|
| CD57 |
NCL-NK1 |
NK-1 |
|
| CD57 |
PA0443 |
NK-1 |
|
| CD57 |
RTU-NK1 |
NK-1 |
|
| CD61 (GPIIIa) |
NCL-CD61-308 |
2f2 |
|
| CD61 (GPIIIa) |
PA0308 |
- |
|
| CD62E (E-selectin) |
NCL-CD62E-382 |
16G4 |
|
| CD62L (L-selectin) |
NCL-CD62L-489 |
9H6 |
|
| CD62P (P-selectin) |
NCL-CD62P-367 |
C34 |
|
| CD63 (Melanoma Marker) |
NCL-CD63 |
NKI/C3 |
|
| CD66a (CEACAM1) |
NCL-CD66a |
29H2 |
|
| CD66e (Carcinoembryonic Antigen) |
NCL-CEA-2 |
12-140-10 |
|
| CD66e (Carcinoembryonic Antigen) |
NCL-L-CEA-2 |
12-140-10 |
|
| CD66e (Carcinoembryonic Antigen) |
RTU-CEA-2 |
12-140-10 |
|
| CD68 |
NCL-CD68 |
514H12 |
|
| CD68 |
NCL-CD68-KP1 |
KP1 |
|
| CD68 |
NCL-L-CD68 |
514H12 |
|
| CD68 |
PA0273 |
514H12 |
|
| CD68 |
RTU-CD68 |
514H12 |
|
| CD69 |
NCL-CD69 |
CH11 |
|
| CD71 |
NCL-CD71-309 |
10F11 |
|
| CD72 |
NCL-CD72 |
D748 |
|
| CD74 |
NCL-LN2 |
LN-2 |
|
| CD75 |
NCL-LN1 |
LN-1 |
|
| CD79a |
NCL-CD79a-192 |
11D10 |
|
| CD79a |
NCL-CD79a-225 |
11E3 |
|
| CD79a |
NCL-L-CD79a-192 |
11D10 |
|
| CD79a |
NCL-L-CD79a-225 |
11E3 |
|
| CD79a |
PA0192 |
11E3 |
|
| CD79a |
RTU-CD79a-192 |
11D10 |
|
| CD79b |
NCL-L-CD79b |
JS01 |
|
| CD81 |
NCL-CD81 |
1D6 |
|
| CD82 |
NCL-CD82 |
5B5 |
|
| CD83 |
NCL-CD83 |
1H4b |
|
| CD95 (Fas) |
NCL-FAS-310 |
GM30 |
|
| CD99 |
NCL-CD99 |
HO36-1.1 |
|
| CD105 (Endoglin) |
NCL-CD105 |
4G11 |
|
| CD117 (c-kit Oncoprotein) |
NCL-CD117 |
T595 |
|
| CD117 (c-kit Oncoprotein) |
NCL-cKIT |
57A5D8 |
|
| CD117 (c-kit Oncoprotein) |
NCL-L-CD117 |
T595 |
|
| CD117 (c-kit Oncoprotein) |
RTU-CD117 |
T595 |
|
| CD134 (OX40) |
NCL-CD134 |
102H6 |
|
| CD137 |
NCL-CD137 |
S16 |
|
| CD141 (Thrombomodulin) |
NCL-CD141 |
15C8 |
|
| CD146 (MCAM) |
NCL-CD146 |
N1238 |
|
| CD151 (PETA-3) |
NCL-CD151 |
RLM30 |
|
| CD163 |
NCL-CD163 |
10D6 |
|
| CD166 (ALCAM) |
NCL-CD166 |
MOG/07 |
|
| CD168 (RHAMM) |
NCL-CD168 |
2D6 |
|
| CD20 |
NCL-CD20-7D1 |
7D1 |
|
| CD20 |
NCL-CD20-L26 |
L26 |
|
| CD20 |
NCL-CD20-MJ1 |
MJ1 |
|
| CD20 |
NCL-L-CD20-L26 |
L26 |
|
| CD20 |
PA0906 |
MJ1 |
|
| CD20 |
RTU-CD20-L26 |
- |
|
| CD205 (DEC-205) |
NCL-L-DEC205 |
11A10 |
|
| CD243 (P-glycoprotein) |
NCL-PGLYm |
5B12 |
|
| CD246 (Anaplastic Lymphoma Kinase) (ALK) (p80) |
NCL-ALK |
5A4 |
|
| CD246 (Anaplastic Lymphoma Kinase) (ALK) (p80) |
PA0306 |
5A4 |
|
| CD3 |
NCL-CD3 |
UCHT1 |
|
| CD3 |
NCL-CD3-PS1 |
PS1 |
|
| CD3 |
NCL-L-CD3-565 |
LN10 |
|
| CD3 |
NCL-L-CD3-PS1 |
PS1 |
|
| CD3 |
PA0553 |
LN10 |
|
| CD3 |
RTU-CD3-PS1 |
PS1 |
|
| CD44 (H-CAM) |
NCL-CD44-2 |
DF1485 |
|
| CD5 |
NCL-CD5-4C7 |
4C7 |
|
| CD5 |
NCL-L-CD5-4C7 |
4C7 |
|
| CD5 |
PA0168 |
4C7 |
|
| CD5 |
RTU-CD5-4C7 |
4C7 |
|
| CDX2 |
NCL-CDX2 |
AMT28 |
|
| CDX2 |
PA0535 |
AMT28 |
|
| CEACAM1 (CD66a) |
NCL-CD66a |
29H2 |
|
| Cellular Apoptosis Susceptibility Protein |
NCL-CAS |
30F12 |
|
| c-erbB-3 Oncoprotein |
NCL-c-erbB-3 |
RTJ1 |
|
| c-fos Oncoprotein |
NCL-FOS |
CF2 |
|
| Checkpoint Kinase 1 |
NCL-Chk1 |
DCS-310.1 |
|
| Cholecystokinin (CCK-8) |
NCL-CCK-8p |
Polyclonal |
|
| Choline Acetyltransferase |
NCL-ChAT |
38B12 |
|
| Chromogranin A |
NCL-CHROM-430 |
5H7 |
|
| Chromogranin A |
PA0430 |
5H7 |
|
| c-jun Oncoprotein |
NCL-cJUN |
DK4 |
|
| c-kit Oncoprotein (CD117) |
NCL-CD117 |
T595 |
|
| c-kit Oncoprotein (CD117) |
NCL-cKIT |
57A5D8 |
|
| c-kit Oncoprotein (CD117) |
NCL-L-CD117 |
T595 |
|
| c-kit Oncoprotein (CD117) |
RTU-CD117 |
T595 |
|
| Clusterin (Apolipoprotein J) |
NCL-CLUSTERIN |
7D1 |
|
| c-MET (Hepatocyte Growth Factor Receptor) |
NCL-cMET |
8F11 |
|
| c-myc Oncoprotein |
NCL-cMYC |
9E11 |
|
| Collagen Type II |
NCL-COLL-IIp |
Polyclonal |
|
| Collagen Type IV |
NCL-COLL-IV |
PHM-12 |
|
| Collagen Type VII |
NCL-COLL-VII |
LH7.2 |
|
| Collagen Type VI (α3 Chain) |
NCL-COLL-VI |
64C11 |
|
| Complement Component C9 |
NCL-CCC9 |
10A6 |
|
| CPP32 (Caspase-3) |
NCL-CPP32 |
JHM62 |
|
| Cyclin A |
NCL-CYCLIN A |
6E6 |
|
| Cyclin B1 |
NCL-CYCLIN B1 |
7A9 |
|
| Cyclin D1 |
NCL-CYCLIN D1 |
DCS-6 |
|
| Cyclin D1 |
NCL-CYCLIN D1-GM |
P2D11F11 |
|
| Cyclin D1 |
NCL-L-CYCLIN D1-GM |
P2D11F11 |
|
| Cyclin D1 |
RTU-CYCLIN D1-GM |
P2D11F11 |
|
| Cyclin D3 |
NCL-CYCLIN D3 |
DCS-22 |
|
| Cyclin Dependent Kinase 4 |
NCL-CDK4-35 |
DCS-35 |
|
| Cyclin E |
NCL-CYCLIN E |
13A3 |
|
| Cyclin G |
NCL-CYCLIN G |
11C8 |
|
| Cyclooxygenase-2 |
NCL-COX-2 |
4H12 |
|
| Cytokeratin, Multi (1/5/10/14) |
NCL-CK34BE12 |
34βE12 |
|
| Cytokeratin, Multi (1/5/10/14) |
PA0134 |
34βE12 |
|
| Cytokeratin, Multi (1/5/10/14) |
RTU-CK34BE12 |
34βE12 |
|
| Cytokeratin 1 |
NCL-CK1 |
34βB4 |
|
| Cytokeratin 4 |
NCL-CK4 |
6B10 |
|
| Cytokeratin 5 |
NCL-CK5 |
XM26 |
|
| Cytokeratin 5 |
NCL-L-CK5 |
XM26 |
|
| Cytokeratin 5 |
PA0468 |
XM26 |
|
| Cytokeratin 5 |
RTU-CK5 |
XM26 |
|
| Cytokeratin 6 |
NCL-CK6 |
LHK6B |
|
| Cytokeratin 7 |
NCL-CK7-OVTL |
OV-TL 12/30 |
|
| Cytokeratin 7 |
NCL-L-CK7-560 |
RN7 |
|
| Cytokeratin 7 |
NCL-L-CK7-OVTL |
OV-TL 12/30 |
|
| Cytokeratin 7 |
PA0942 |
RN7 |
|
| Cytokeratin 7 |
RTU-CK7-OVTL |
OV-TL 12/30 |
|
| Cytokeratin 8 |
NCL-CK8-TS1 |
TS1 |
|
| Cytokeratin 8 |
NCL-L-CK8-TS1 |
TS1 |
|
| Cytokeratin 8 |
RTU-CK8-TS1 |
TS1 |
|
| Cytokeratin 10 |
NCL-CK10 |
LHP1 |
|
| Cytokeratin 13 |
NCL-CK13 |
KS-1A3 |
|
| Cytokeratin 14 |
NCL-L-LL002 |
LL002 |
|
| Cytokeratin 14 |
NCL-LL002 |
LL002 |
|
| Cytokeratin 14 |
RTU-LL002 |
LL002 |
|
| Cytokeratin 15 |
NCL-CK15 |
LHK15 |
|
| Cytokeratin 16 |
NCL-CK16 |
LL025 |
|
| Cytokeratin 17 |
NCL-CK17 |
E3 |
|
| Cytokeratin 18 |
NCL-CK18 |
DC-10 |
|
| Cytokeratin 19 |
NCL-CK19 |
b170 |
|
| Cytokeratin 19 |
PA0799 |
b170 |
|
| Cytokeratin 20 |
NCL-CK20 |
Ks20.8 |
|
| Cytokeratin 20 |
NCL-CK20-543 |
CK205 |
|
| Cytokeratin 20 |
NCL-L-CK20 |
Ks20.8 |
|
| Cytokeratin 20 |
NCL-L-CK20-561 |
PW31 |
|
| Cytokeratin 20 |
PA0918 |
PW31 |
|
| Cytokeratin 20 |
RTU-CK20 |
Ks20.8 |
|
| Cytokeratin (5/18) |
NCL-C50 |
C-50 |
|
| Cytokeratin (5/6/18) |
NCL-L-LP34 |
LP34 |
|
| Cytokeratin (5/6/18) |
NCL-LP34 |
LP34 |
|
| Cytokeratin (5/6/18) |
RTU-LP34 |
LP34 |
|
| Cytokeratin (8/18) |
NCL-5D3 |
5D3 |
|
| Cytokeratin (8/18) |
NCL-L-5D3 |
5D3 |
|
| Cytokeratin (8/18) |
PA0067 |
5D3 |
|
| Cytokeratin (8/18) |
RTU-5D3 |
5D3 |
|
| Cytokeratin, Multi (4/5/6/8/10/13/18) |
NCL-C11 |
C-11 |
|
| Cytokeratin, Multi |
NCL-AE1/AE3 |
Clone AE1, AE3 |
|
| Cytokeratin, Multi |
NCL-L-AE1/AE3 |
Clone AE1, AE3 |
|
| Cytokeratin, Multi |
PA0909 |
Clone AE1, AE3 |
|
| Cytokeratin, Multi |
RTU-AE1/AE3 |
Clone AE1, AE3 |
|
| Cytokeratin, Multi (5/6/8/18) |
NCL-CK5/6/8/18 |
5D3, LP34 |
|
| Cytokeratin, Multi (5/6/8/18) |
NCL-L-CK5/6/8/18 |
5D3, LP34 |
|
| Cytokeratin, Multi (5/6/8/18) |
RTU-CK5/6/8/18 |
5D3, LP34 |
|
| Cytomegalovirus Antibodies |
NCL-CMV-EA |
QB1/42 |
|
| Cytomegalovirus Antibodies |
NCL-CMV-LA |
QB1/06 |
|
| Cytomegalovirus Antibodies |
NCL-CMVpp65 |
Clone 2, 6 cocktail |
|
| Daxx |
NCL-DAXX |
36H11 |
|
| DEC-205 (CD205) |
NCL-L-DEC205 |
11A10 |
|
| Deleted in Colorectal Cancer Protein |
NCL-DCC |
DM51 |
|
| Deleted in Pancreatic Cancer Locus 4 Protein |
NCL-DPC4 |
JM56 |
|
| Desmin |
NCL-DES-DERII |
DE-R-11 |
|
| Desmin |
NCL-L-DES-DERII |
DE-R-11 |
|
| Desmin |
PA0032 |
DE-R-11 |
|
| Desmin |
RTU-DES-DERII |
DE-R-11 |
|
| DOG-1 |
NCL-L-DOG-1 |
K9 |
|
| DOG-1 |
PA0219 |
K9 |
|
| Dysferlin |
NCL-Hamlet |
Ham1/7B6 |
|
| Dysferlin |
NCL-Hamlet-2 |
Ham3/17B2 |
|
| Dystrophin Antibodies |
NCL-DYS1 |
Dy4/6D3 |
|
| Dystrophin Antibodies |
NCL-DYS2 |
Dy8/6C5 |
|
| Dystrophin Antibodies |
NCL-DYS3 |
Dy10/12B2 |
|
| Dystrophin Antibodies |
NCL-DYSA |
13H6 |
|
| Dystrophin Antibodies |
NCL-DYSB |
34C5 |
|
| E-Cadherin |
NCL-E-Cad |
36B5 |
|
| E-Cadherin |
PA0387 |
36B5 |
|
| E-Cadherin |
RTU-E-Cad |
36B5 |
|
| Elastin |
NCL-ELASTIN |
BA-4 |
|
| Emerin |
NCL-EMERIN |
4G5 |
|
| Endoglin (CD105) |
NCL-CD105 |
4G11 |
|
| Endothelial Cell Marker (CD34) |
NCL-END |
QBEnd/10 |
|
| Endothelial Cell Marker (CD34) |
NCL-L-END |
QBEnd/10 |
|
| Endothelial Cell Marker (CD34) |
PA0212 |
QBEnd/10 |
|
| Endothelial Cell Marker (CD34) |
RTU-END |
QBEnd/10 |
|
| Endothelin-1 Receptor (ETA) |
NCL-L-ETA |
RJT24 |
|
| Entactin |
NCL-ENTACTIN |
1H12 |
|
| Enterovirus |
NCL-ENTERO |
5-D8/1 |
|
| Envoplakin |
NCL-ENVO |
CRENV-1 |
|
| Epidermal Growth Factor Receptor |
NCL-EGFR |
EGFR.113 |
|
| Epidermal Growth Factor Receptor |
NCL-EGFR-384 |
EGFR.25 |
|
| Epidermal Growth Factor Receptor |
NCL-L-EGFR |
EGFR.113 |
|
| Epidermal Growth Factor Receptor |
NCL-L-EGFR-384 |
EGFR.25 |
|
| Epidermal Growth Factor Receptor |
RTU-EGFR-384 |
EGFR.25 |
|
| Epithelial Membrane Antigen |
NCL-EMA |
GP1.4 |
|
| Epithelial Membrane Antigen |
NCL-L-EMA |
GP1.4 |
|
| Epithelial Membrane Antigen |
PA0035 |
GP1.4 |
|
| Epithelial Membrane Antigen |
RTU-EMA |
GP1.4 |
|
| Epithelial-Related Antigen |
NCL-MOC-31 |
MOC-31 |
|
| Epithelial Specific Antigen |
NCL-ESA |
VU-1D9 |
|
| Epithelial Specific Antigen |
RTU-ESA |
VU-1D9 |
|
| Epstein-Barr virus (nuclear antigen 2) |
NCL-EBV-PE2 |
PE2 |
|
| Epstein-Barr virus (early antigens) Antibodies |
NCL-EADE31 |
G3-E31 |
|
| Epstein-Barr virus (early antigens) Antibodies |
NCL-EARF2 |
W1-F2 |
|
| Epstein-Barr virus-Induced Gene 3 Protein |
NCL-EBI-3 |
EL8 |
|
| Epstein-Barr virus (LMP-1) |
NCL-EBV-CS1-4 |
CS1/CS2/CS3/CS4, cocktail |
|
| E-selectin (CD62E) |
NCL-CD62E-382 |
16G4 |
|
| Estrogen and Progesterone Receptor Antibodies (duo packs) |
NCL-ER/PGR-312d |
6F11, Clone 1A6 |
|
| Estrogen and Progesterone Receptor Antibodies (duo packs) |
NCL-ER/PGRd |
6F11, Clone 1A6 |
|
| Estrogen Receptor (beta) |
NCL-ER-beta |
EMR02 |
|
| Estrogen Receptor |
NCL-ER-6F11 |
6F11 |
|
| Estrogen Receptor |
NCL-ER-6F11/2 |
6F11 |
|
| Estrogen Receptor |
NCL-L-ER-6F11 |
6F11 |
|
| Estrogen Receptor |
NCL-L-ER-6F11/2 |
6F11 |
|
| Estrogen Receptor |
PA0151 |
6F11 |
|
| Estrogen Receptor |
RTU-ER-6F11 |
6F11 |
|
| Ets-1 Oncoprotein |
NCL-ETS-1 |
1G11 |
|
| Excitatory Amino Acid Transporter Antibodies |
NCL-EAAT1 |
10D4 |
|
| Excitatory Amino Acid Transporter Antibodies |
NCL-EAAT2 |
1H8 |
|
| EZH2 (Enhancer of Zeste Homolog 2 (Drosophila)) |
NCL-L-EZH2 |
6A10 |
|
| Factor VIII (von Willebrand Factor) |
NCL-L-vWF |
36B11 |
|
| Factor VIII (von Willebrand Factor) |
NCL-vWF |
36B11 |
|
| Factor VIII (von Willebrand Factor) |
PA0400 |
36B11 |
|
| Factor XIIIa (Blood Coagulation Factor XIIIa) |
NCL-FXIIIa |
E980.1 |
|
| Factor XIIIa (Blood Coagulation Factor XIIIa) |
PA0449 |
E980.1 |
|
| Fascin |
NCL-FASCIN |
IM20 |
|
| Fascin |
NCL-L-FASCIN |
IM20 |
|
| Fascin |
PA0420 |
- |
|
| Fas-Associated Death Domain Protein |
NCL-FADD |
64A6 |
|
| Fas-Associated Phosphatase-1 |
NCL-FAP-1 |
AC21 |
|
| Fas (CD95) |
NCL-FAS-310 |
GM30 |
|
| Fas Ligand |
NCL-FAS-L |
5D1 |
|
| Feline Calicivirus (capsid protein) |
NCL-1G9 |
1G9 |
|
| Fibronectin |
NCL-FIB |
568 |
|
| Filaggrin |
NCL-FILAGGRIN |
15C10 |
|
| Filamin |
NCL-FIL |
PM6/317 |
|
| Galectin-1 |
NCL-GAL1 |
25C1 |
|
| Galectin-3 |
NCL-GAL3 |
9C4 |
|
| Galectin-4 |
NCL-L-GAL4 |
8A6 |
|
| Gamma-Catenin |
NCL-G-CAT |
11B6 |
|
| Gamma-Synuclein |
NCL-L-GSYN |
KC30 |
|
| GAP43 |
NCL-GAP43 |
1G7 |
|
| Gastrin |
NCL-GASp |
Polyclonal |
|
| Geminin |
NCL-L-Geminin |
EM6 |
|
| Giardia intestinalis |
NCL-GI |
9D5.3.1 |
|
| Glial Fibrillary Acidic Protein |
NCL-GFAP-GA5 |
GA5 |
|
| Glial Fibrillary Acidic Protein |
PA0026 |
GA5 |
|
| Glucagon |
NCL-GLUCp |
Polyclonal |
|
| Glucocorticoid Receptor |
NCL-GCR |
4H2 |
|
| Glutathione S-Transferase (GST) Antibodies |
NCL-GSTal-436 |
38H11 |
|
| Glutathione S-Transferase (GST) Antibodies |
NCL-GSTmu-437 |
10H6 |
|
| Glutathione S-Transferase (GST) Antibodies |
NCL-GSTpi-438 |
LW29 |
|
| Gonadotropin-Releasing Hormone Receptor |
NCL-GnRHR |
A9E4 |
|
| GPIb (CD42b) |
NCL-CD42b |
MM2/174 |
|
| GPIIb/IIIa (CD41) |
NCL-CD41 |
M148 |
|
| GPIIIa (CD61) |
NCL-CD61-308 |
2f2 |
|
| GPIIIa (CD61) |
PA0308 |
- |
|
| Granulysin |
NCL-L-Granulysin |
RJT48 |
|
| Granzyme B |
NCL-GRAN-B |
11F1 |
|
| Granzyme B |
NCL-L-GRAN-B |
11F1 |
|
| Granzyme B |
PA0291 |
11F1 |
|
| Granzyme B |
RTU-GRAN-B |
11F1 |
|
| Gross Cystic Disease Fluid Protein-15 |
NCL-GCDFP15 |
23A3 |
|
| Gross Cystic Disease Fluid Protein-15 |
NCL-L-GCDFP15 |
23A3 |
|
| Gross Cystic Disease Fluid Protein-15 |
PA0350 |
23A3 |
|
| Gross Cystic Disease Fluid Protein-15 |
RTU-GCDFP15 |
23A3 |
|
| Heat Shock Protein 27 |
NCL-HSP27 |
2B4 |
|
| Heat Shock Protein 70 |
NCL-HSP70 |
8B11 |
|
| Heat Shock Protein 90 |
NCL-HSP90 |
JPB24 |
|
| Heat Shock Protein 105 |
NCL-HSP105 |
58F12 |
|
| Helicobacter pylori |
NCL-HPp |
Polyclonal |
|
| Hepatitis B virus Antibodies |
NCL-HBcAg-506 |
LF161 |
|
| Hepatitis B virus Antibodies |
NCL-HBsAg-2 |
1044/341 |
|
| Hepatitis C virus (NS3) |
NCL-HCV-NS3 |
MMM33 |
|
| Hepatocyte Growth Factor Receptor (c-MET) |
NCL-cMET |
8F11 |
|
| Hepatocyte Specific Antigen |
NCL-HSA |
OCH1E5 |
|
| Heregulin |
NCL-HEREG |
P137 |
|
| Herpes simplex virus Antibodies |
NCL-HSV-1 |
20.7.1 |
|
| Herpes simplex virus Antibodies |
NCL-HSV-2 |
12.3.4, 1.1.1 |
|
| HER-2 (c-erbB-2 Oncoprotein) Antibodies |
NCL-c-erbB-2-316 |
5A2 |
|
| HER-2 (c-erbB-2 Oncoprotein) Antibodies |
NCL-CB11 |
CB11 |
|
| HER-2 (c-erbB-2 Oncoprotein) Antibodies |
NCL-CBE-356 |
10A7 |
|
| HER-2 (c-erbB-2 Oncoprotein) Antibodies |
NCL-CBE1 |
CBE1 |
|
| HER-2 (c-erbB-2 Oncoprotein) Antibodies |
NCL-L-CB11 |
CB11 |
|
| HER-2 (c-erbB-2 Oncoprotein) Antibodies |
RTU-CB11 |
CB11 |
|
| HER-2 (c-erbB-2 Oncoprotein) Antibodies |
RTU-CBE-356 |
10A7 |
|
| HFSH (beta 2) (Human Follicle Stimulating Hormone) |
NCL-HFSH |
INN-hFSH-60 |
|
| HFSH (beta 2) (Human Follicle Stimulating Hormone) |
PA0693 |
INN-hFSH-60 |
|
| HGH (Human Growth Hormone) |
NCL-HGH |
Polyclonal |
|
| HGH (Human Growth Hormone) |
PA0704 |
- |
|
| HGM-45M1 (Human Gastric Mucin) |
NCL-HGM-45M1 |
45M1 |
|
| HLA Class II (DR) Antigen |
NCL-LN3 |
LN-3 |
|
| HMB45 (Melanoma Marker) |
NCL-HMB45 |
HMB45 |
|
| Human Chorionic Gonadotrophin (beta) |
NCL-HCGp |
Polyclonal |
|
| Human Chorionic Gonadotrophin (beta) |
PA0014 |
- |
|
| Human Chorionic Gonadotrophin (alpha) |
NCL-HCG-alpha |
4E12 |
|
| Human Follicle Stimulating Hormone (beta 2) (HFSH) |
NCL-HFSH |
INN-hFSH-60 |
|
| Human Follicle Stimulating Hormone (beta 2) (HFSH) |
PA0693 |
INN-hFSH-60 |
|
| Human Gastric Mucin (HGM-45M1) |
NCL-HGM-45M1 |
45M1 |
|
| Human Growth Hormone (HGH) |
NCL-HGH |
Polyclonal |
|
| Human Growth Hormone (HGH) |
PA0704 |
- |
|
| Human Herpesvirus (type 8) (latent nuclear antigen) |
NCL-HHV8-LNA |
13B10 |
|
| Human Neutrophil Defensins (1/2/3) |
NCL-DEFENSIN |
D21 |
|
| Human Securin |
NCL-SECURIN |
DCS-280.2 |
|
| Human Spasmolytic Polypeptide |
NCL-HSP |
GE16C |
|
| H-CAM (CD44) |
NCL-CD44-2 |
DF1485 |
|
| Human von Willebrand Factor (Factor VIII-related antigen) |
NCL-L-vWF |
36B11 |
|
| Human von Willebrand Factor (Factor VIII-related antigen) |
NCL-vWF |
36B11 |
|
| Human von Willebrand Factor (Factor VIII-related antigen) |
PA0400 |
36B11 |
|
| ICAM-1 (CD54) |
NCL-CD54-307 |
23G12 |
|
| Immunoglobulin M |
NCL-L-IgM |
8H6 |
|
| Immunoglobulin Antibodies |
NCL-IgAp |
Polyclonal |
|
| Immunoglobulin Antibodies |
NCL-IgDp |
Polyclonal |
|
| Immunoglobulin Antibodies |
NCL-IgGp |
Polyclonal |
|
| Immunoglobulin Antibodies |
NCL-IgMp |
Polyclonal |
|
| Immunoglobulin A |
NCL-L-IgA |
N1CLA |
|
| Immunoglobulin D |
NCL-L-IgD |
DRN1C |
|
| Insulin |
NCL-INSULIN |
2D11-H5 |
|
| Insulin |
PA0620 |
2D11-H5 |
|
| Interleukin-2 Receptor (CD25) |
NCL-CD25-305 |
4C9 |
|
| Interleukin-2 Receptor (CD25) |
PA0368 |
4C9 |
|
| Interleukin 6 |
NCL-L-IL6 |
10C12 |
|
| Involucrin |
NCL-INV |
SY5 |
|
| Kappa Light Chain |
NCL-KAP |
kp-53 |
|
| Kappa Light Chain |
NCL-KAP-L1C1 |
L1C1 |
|
| Ki67 Antigen |
NCL-Ki67-MM1 |
MM1 |
|
| Ki67 Antigen |
NCL-Ki67p |
Polyclonal |
|
| Ki67 Antigen |
NCL-L-Ki67-MM1 |
MM1 |
|
| Ki67 Antigen |
PA0118 |
MM1 |
|
| Ki67 Antigen |
RTU-Ki67-MM1 |
MM1 |
|
| Kip2 (p57 Protein) |
NCL-p57 |
25B2 |
|
| Lambda Light Chain |
NCL-LAM |
HP-6054 |
|
| Lambda Light Chain |
NCL-LAMp |
Polyclonal |
|
| Laminin |
NCL-LAMININ |
LAM-89 |
|
| Lamin |
NCL-LAM-A/C |
636 |
|
| Langerin |
NCL-LANGERIN |
12D6 |
|
| LFA-2 (CD2) |
NCL-CD2-271 |
AB75 |
|
| LFA-2 (CD2) |
NCL-L-CD2-271 |
AB75 |
|
| LFA-2 (CD2) |
PA0271 |
11F11 |
|
| LFA-2 (CD2) |
RTU-CD2-271 |
AB75 |
|
| Linker for Activation of T Cells |
NCL-L-LAT |
3.8 |
|
| LMP-1 (Epstein-Barr virus) |
NCL-EBV-CS1-4 |
CS1/CS2/CS3/CS4, cocktail |
|
| Lung Resistance-Related Protein (110 kD) |
NCL-LRRP |
9D6 |
|
| Lysozyme (Muramidase) |
NCL-MURAM |
Polyclonal |
|
| L-selectin (CD62L) |
NCL-CD62L-489 |
9H6 |
|
| Macrophage Marker (3A5) |
NCL-MACRO |
3A5 |
|
| Macrophage Marker (LN-5) |
NCL-LN5 |
LN-5 |
|
| Macrophage Marker (MAC387) |
NCL-MAC387 |
MAC387 |
|
| Macrophage Marker (MAC387) |
PA0752 |
MAC387 |
|
| Mac-1 (CD11b) |
NCL-CD11b |
44 |
|
| MAGE-1 |
NCL-MAGE-1 |
6C1 |
|
| Maspin |
NCL-MASPIN |
EAW24 |
|
| Mast Cell Chymase |
NCL-MCC |
CC1 |
|
| Mast Cell Tryptase |
NCL-MCTRYP-428 |
10D11 |
|
| Mast Cell Tryptase |
PA0019 |
10D11 |
|
| Matrix Metalloproteinase Antibodies |
NCL-MMP10 |
5E4 |
|
| Matrix Metalloproteinase Antibodies |
NCL-MMP19 |
9F6 |
|
| Matrix Metalloproteinase Antibodies |
NCL-MMP2-507 |
17B11 |
|
| Matrix Metalloproteinase Antibodies |
NCL-MMP9-439 |
15W2 |
|
| MB2 (B Cell Marker) |
NCL-MB2 |
MB2 |
|
| MCAM (CD146) |
NCL-CD146 |
N1238 |
|
| Mcl-1 |
NCL-Mcl-1 |
38G3 |
|
| MDM2 Protein |
NCL-MDM2 |
1B10 |
|
| Melanoma Marker (CD63) |
NCL-CD63 |
NKI/C3 |
|
| Melanoma Marker (HMB45) |
NCL-HMB45 |
HMB45 |
|
| Melan A |
NCL-L-MelanA |
A103 |
|
| Melan A |
NCL-MelanA |
A103 |
|
| Melan A |
PA0233 |
A103 |
|
| Melan A |
RTU-MelanA |
A103 |
|
| Merosin Laminin Alpha 2 Chain |
NCL-MEROSIN |
Mer3/22B2 |
|
| Mesothelin |
NCL-L-MESO |
5B2 |
|
| Mesothelin |
NCL-MESO |
5B2 |
|
| Mesothelin |
PA0373 |
5B2 |
|
| Microphthalmia Transcription Factor (MITF) |
NCL-L-MITF |
34CA5 |
|
| Microphthalmia Transcription Factor (MITF) |
NCL-MITF |
34CA5 |
|
| Minichromosome Maintenance Protein 6 |
NCL-L-MCM6 |
KAT82 |
|
| Minichromosome Maintenance Protein Antibodies |
NCL-MCM2 |
CRCT2.1 |
|
| Minichromosome Maintenance Protein Antibodies |
NCL-MCM3 |
JCC07 |
|
| Minichromosome Maintenance Protein Antibodies |
NCL-MCM5 |
CRCT5.1 |
|
| Minichromosome Maintenance Protein Antibodies |
NCL-MCM7 |
DCS-141.1 |
|
| Mismatch Repair Protein 2 (MSH2) |
NCL-MSH2 |
25D12 |
|
| Mismatch Repair Protein 6 (MSH6) |
NCL-L-MSH6 |
PU29 |
|
| Mismatch Repair Protein (MLH1) |
NCL-L-MLH1 |
ES05 |
|
| Mitogen-Activated Protein Kinase Kinase 4 |
NCL-MKK4 |
7A6 |
|
| Motility-Related Protein-1 (CD9) |
NCL-CD9 |
72F6 |
|
| Muc Glycoprotein Antibodies |
NCL-MUC-1 |
Ma695 |
|
| Muc Glycoprotein Antibodies |
NCL-MUC-1-CORE |
Ma552 |
|
| Muc Glycoprotein Antibodies |
NCL-MUC-2 |
Ccp58 |
|
| Muc Glycoprotein Antibodies |
NCL-MUC-5AC |
CLH2 |
|
| Muc Glycoprotein Antibodies |
NCL-MUC-6 |
CLH5 |
|
| Multidrug Resistance-Associated Protein Antibodies |
NCL-MRP1 |
33A6 |
|
| Multidrug Resistance-Associated Protein Antibodies |
NCL-MRP3 |
DTX1 |
|
| Multi-Cytokeratin 1/5/10/14 |
NCL-CK34BE12 |
34βE12 |
|
| Multi-Cytokeratin 1/5/10/14 |
PA0134 |
34βE12 |
|
| Multi-Cytokeratin 1/5/10/14 |
RTU-CK34BE12 |
34βE12 |
|
| Multi-Cytokeratin (4/5/6/8/10/13/18) |
NCL-C11 |
C-11 |
|
| Multi-Cytokeratin (5/6/8/18) |
NCL-CK5/6/8/18 |
5D3, LP34 |
|
| Multi-Cytokeratin (5/6/8/18) |
NCL-L-CK5/6/8/18 |
5D3, LP34 |
|
| Multi-Cytokeratin (5/6/8/18) |
RTU-CK5/6/8/18 |
5D3, LP34 |
|
| Multi-Cytokeratin |
NCL-AE1/AE3 |
Clone AE1, AE3 |
|
| Multi-Cytokeratin |
NCL-L-AE1/AE3 |
Clone AE1, AE3 |
|
| Multi-Cytokeratin |
PA0909 |
Clone AE1, AE3 |
|
| Multi-Cytokeratin |
RTU-AE1/AE3 |
Clone AE1, AE3 |
|
| Muscle Specific Actin |
NCL-MSA |
HHF35 |
|
| Muscle Specific Actin |
PA0258 |
- |
|
| Mycobacterium tuberculosis |
NCL-MT |
1.1/3/1 |
|
| Myelin Basic Protein |
NCL-MBP |
7H11 |
|
| Myeloid Marker (BM1) |
NCL-BM1 |
BM-1 |
|
| Myeloid Marker (BM2) |
NCL-BM2 |
BM-2 |
|
| Myeloperoxidase |
NCL-MYELO |
59A5 |
|
| Myogenin (Myf-4) |
NCL-L-Myf-4 |
LO26 |
|
| Myogenin (Myf-4) |
NCL-Myf-4 |
LO26 |
|
| Myogenin (Myf-4) |
PA0226 |
LO26 |
|
| Myoglobin |
NCL-MYOGLOBIN |
MYO18 |
|
| Myoglobin |
PA0727 |
MYO18 |
|
| Myosin Heavy Chain Antibodies |
NCL-MHC-Sm |
S131 |
|
| Myosin Heavy Chain Antibodies |
NCL-MHCd |
RNMy2/9D2 |
|
| Myosin Heavy Chain Antibodies |
NCL-MHCf |
WB-MHCf |
|
| Myosin Heavy Chain Antibodies |
NCL-MHCn |
WB-MHCn |
|
| Myosin Heavy Chain Antibodies |
NCL-MHCs |
WB-MHCs |
|
| Myosin Heavy Chain Antibodies |
PA0493 |
S131 |
|
| Myotilin |
NCL-MYOTILIN |
RSO34 |
|
| N-Cadherin |
NCL-L-N-Cad |
IAR06 |
|
| Napsin |
NCL-L-NapsinA |
IP64 |
|
| NCAM (CD56) |
NCL-CD56-1B6 |
1B6 |
|
| NCAM (CD56) |
NCL-CD56-504 |
CD564 |
|
| NCAM (CD56) |
NCL-L-CD56-1B6 |
1B6 |
|
| NCAM (CD56) |
PA0191 |
CD564 |
|
| NCAM (CD56) |
RTU-CD56-1B6 |
1B6 |
|
| Nerve Growth Factor Receptor (gp75) |
NCL-NGFR |
7F10 |
|
| Neuroblastoma Marker |
NCL-NB84 |
NB84a |
|
| Neurofilament Antibodies |
NCL-NF200 |
RT97 |
|
| Neurofilament Antibodies |
NCL-NF200-N52 |
N52.1.7 |
|
| Neurofilament Antibodies |
NCL-NF68 |
NR4 |
|
| Neurofilament Antibodies |
NCL-NF68-DA2 |
DA2 |
|
| Neuron Specific Enolase |
NCL-L-NSE2 |
5E2 |
|
| Neuron Specific Enolase |
NCL-NSE-435 |
22C9 |
|
| Neuron Specific Enolase |
NCL-NSE2 |
5E2 |
|
| Neuron Specific Enolase |
PA0435 |
22C9 |
|
| Neuron Specific Enolase |
RTU-NSE2 |
5E2 |
|
| Nitric Oxide Synthase Antibodies |
NCL-NOS-1 |
NOS-125 |
|
| Nitric Oxide Synthase Antibodies |
NCL-NOS-3 |
RN5 |
|
| nm23 Protein |
NCL-nm23 |
37.6 |
|
| NS3 (Hepatitis C virus) |
NCL-HCV-NS3 |
MMM33 |
|
| Nucleoporin (88 kD) |
NCL-Nup88 |
JRC1 |
|
| Oct-2 |
NCL-OCT2 |
Oct-207 |
|
| Oct-2 |
PA0532 |
Oct-207 |
|
| Oct-3/4 |
NCL-L-Oct3/4 |
N1NK |
|
| Osteonectin |
NCL-O-NECTIN |
15G12 |
|
| Osteopontin |
NCL-O-PONTIN |
OP3N |
|
| Ovarian Cancer Antigen (CA125) |
NCL-CA125 |
Ov185:1 |
|
| Ovarian Cancer Antigen (CA125) |
NCL-L-CA125 |
Ov185:1 |
|
| Ovarian Cancer Antigen (CA125) |
PA0539 |
Ov185:1 |
|
| Ovarian Cancer Antigen (CA125) |
RTU-CA125 |
Ov185:1 |
|
| OX40 (CD134) |
NCL-CD134 |
102H6 |
|
| p21 (WAF1 Protein) |
NCL-L-WAF-1 |
4D10 |
|
| p21 (WAF1 Protein) |
NCL-WAF-1 |
4D10 |
|
| p27 Protein |
NCL-p27 |
1B4 |
|
| p53 Protein (1801) |
NCL-p53-1801 |
PAb 1801 |
|
| p53 Protein (BP53-12) |
NCL-p53-BP |
BP53-12 |
|
| p53 Protein (CM1) |
NCL-p53-CM1 |
Polyclonal |
|
| p53 Protein (DO-1) |
NCL-p53-DO1 |
DO-1 |
|
| p53 Protein |
NCL-p53-505 |
IMX25 |
|
| p53 Protein |
PA0057 |
IMX25 |
|
| p53 Protein (Phosphospecific) |
NCL-p53-PHOS |
FP3-2 |
|
| p57 Protein (Kip2) |
NCL-p57 |
25B2 |
|
| p63 Protein |
NCL-p63 |
7JUL |
|
| p63 Protein |
PA0478 |
7JUL |
|
| p73 Protein (alpha) |
NCL-p73 |
24 |
|
| p80 (Anaplastic Lymphoma Kinase) (ALK) (CD246) |
NCL-ALK |
5A4 |
|
| p80 (Anaplastic Lymphoma Kinase) (ALK) (CD246) |
PA0306 |
5A4 |
|
| p53 Protein (CM5) |
NCL-p53-CM5p |
Polyclonal |
|
| p53 Protein (DO-7) |
NCL-L-p53-DO7 |
DO-7 |
|
| p53 Protein (DO-7) |
NCL-p53-DO7 |
DO-7 |
|
| p53 Protein (DO-7) |
PA0057 |
DO-7 |
|
| p53 Protein (DO-7) |
RTU-p53-DO7 |
DO-7 |
|
| Papillomavirus Antibodies |
NCL-HPV-4C4 |
4C4 |
|
| Papillomavirus Antibodies |
NCL-HPV18 |
5A3 |
|
| Parathyroid Hormone |
NCL-PTH-488 |
105G7 |
|
| Parvalbumin (Alpha) |
NCL-PARVALBUMIN |
2E11 |
|
| Parvovirus B19 |
NCL-PARVO |
R92F6 |
|
| Pax-5 |
NCL-L-PAX-5 |
1EW |
|
| Pax-5 |
PA0552 |
1EW |
|
| PECAM-1 (CD31) |
NCL-CD31-1A10 |
1A10 |
|
| PECAM-1 (CD31) |
PA0250 |
1A10 |
|
| Perforin |
NCL-PERFORIN |
5B10 |
|
| Peripherin |
NCL-PERIPH |
PJM50 |
|
| PETA-3 (CD151) |
NCL-CD151 |
RLM30 |
|
| Placental Alkaline Phosphatase |
NCL-L-PLAP-8A9 |
8A9 |
|
| Placental Alkaline Phosphatase |
NCL-PLAP-8A9 |
8A9 |
|
| Placental Alkaline Phosphatase |
PA0161 |
8A9 |
|
| Placental Alkaline Phosphatase |
RTU-PLAP-8A9 |
8A9 |
|
| Placental Lactogen |
NCL-PLp |
Polyclonal |
|
| Plasma Cell Marker |
NCL-PC |
LIV3G11 |
|
| Plasminogen Activator Inhibitor (Type 1) |
NCL-PAI-1 |
TJA6 |
|
| Platelet-Derived Endothelial Growth Factor |
NCL-PDEGF |
P-GF.44C |
|
| Pneumolysin |
NCL-SPNm |
9.1/2/3/6 |
|
| Polyomavirus |
NCL-JCBK |
3.1.1 |
|
| Prealbumin |
NCL-PREp |
Polyclonal |
|
| Progesterone and Estrogen Receptor Antibodies (duo packs) |
NCL-ER/PGR-312d |
6F11, Clone 1A6 |
|
| Progesterone and Estrogen Receptor Antibodies (duo packs) |
NCL-ER/PGRd |
6F11, Clone 1A6 |
|
| Progesterone Receptor (A/B Forms) |
NCL-L-PGR-AB |
Clone 16, SAN27 |
|
| Progesterone Receptor (A/B Forms) |
NCL-PGR-AB |
Clone 16, SAN27 |
|
| Progesterone Receptor (A/B Forms) |
RTU-PGR-AB |
Clone 16, SAN27 |
|
| Progesterone Receptor (B Form) |
NCL-PGR-B |
SAN27 |
|
| Progesterone Receptor |
NCL-L-PGR |
1A6 |
|
| Progesterone Receptor |
NCL-L-PGR-312 |
16 |
|
| Progesterone Receptor |
NCL-PGR |
1A6 |
|
| Progesterone Receptor |
NCL-PGR-312 |
16 |
|
| Progesterone Receptor |
NCL-PGR-312/2 |
16 |
|
| Progesterone Receptor |
NCL-PGR/2 |
1A6 |
|
| Progesterone Receptor |
PA0312 |
16 |
|
| Progesterone Receptor |
RTU-PGR |
1A6 |
|
| Progesterone Receptor |
RTU-PGR-312 |
16 |
|
| Proinsulin |
NCL-PROIN-1G4 |
1G4 |
|
| Proliferating Cell Nuclear Antigen |
NCL-L-PCNA |
PC10 |
|
| Proliferating Cell Nuclear Antigen |
NCL-PCNA |
PC10 |
|
| Prostate Specific Antigen |
NCL-L-PSA-28A4 |
PSA 28/A4 |
|
| Prostate Specific Antigen |
NCL-PSA-431 |
35H9 |
|
| Prostate Specific Antigen |
PA0431 |
35H9 |
|
| Prostate Specific Antigen |
RTU-PSA-28A4 |
PSA 28/A4 |
|
| Prostate Specific Membrane Antigen |
NCL-L-PSMA |
1D6 |
|
| Prostate Tumor Overexpressed Protein 1 |
NCL-PTOV1 |
17C6 |
|
| Prostatic Acid Phosphatase |
NCL-L-PAP |
PASE/4LJ |
|
| Prostatic Acid Phosphatase |
PA0006 |
PASE/4LJ |
|
| Prostatic Inhibin Peptide |
NCL-PIP |
4A6A6 |
|
| Protein Gene Product 9.5 |
NCL-L-PGP9.5 |
10A1 |
|
| Protein Gene Product 9.5 |
NCL-PGP9.5 |
10A1 |
|
| Protein Gene Product 9.5 |
PA0286 |
10A1 |
|
| pS2 Protein |
NCL-pS2 |
Polyclonal |
|
| PTEN |
NCL-PTEN |
28H6 |
|
| P-Cadherin |
NCL-P-Cad |
56C1 |
|
| P-glycoprotein (CD243) |
NCL-PGLYm |
5B12 |
|
| P-selectin (CD62P) |
NCL-CD62P-367 |
C34 |
|
| Renal Cell Carcinoma Marker |
NCL-RCC |
66.4.C2 |
|
| Respiratory syncytial virus |
NCL-RSV3 |
5H5N, G122ends |
|
| Retinoblastoma Gene Protein |
NCL-L-RB-358 |
13A10 |
|
| Retinoblastoma Gene Protein |
NCL-RB |
1F8 |
|
| Retinoblastoma Gene Protein |
NCL-RB-358 |
13A10 |
|
| ret Oncoprotein |
NCL-RET |
3F8 |
|
| RHAMM (CD168) |
NCL-CD168 |
2D6 |
|
| S100A7 (Psoriasin) |
NCL-L-S100-A7 |
3DC |
|
| Sarcoglycan Antibodies |
NCL-a-SARC |
Ad1/20A6 |
|
| Sarcoglycan Antibodies |
NCL-b-SARC |
βSarc1/5B1 |
|
| Sarcoglycan Antibodies |
NCL-d-SARC |
δSarc3/12C1 |
|
| Sarcoglycan Antibodies |
NCL-g-SARC |
35DAG/21B5 |
|
| Sarcoglycan Antibodies |
NCL-L-a-SARC |
Ad1/20A6 |
|
| Sarcoglycan Antibodies |
NCL-L-b-SARC |
βSarc1/5B1 |
|
| Sarcoplasmic or Endoplasmic Reticulum Ca2+ ATPase (SERCA) Antibodies |
NCL-SERCA2 |
IID8 |
|
| Serotonin |
NCL-SEROTp |
Polyclonal |
|
| Serotonin |
PA0736 |
- |
|
| Sialyl Lewisa (CA19-9) |
NCL-CA19-9 |
C241:5:1:4 |
|
| Sialyl Lewisa (CA19-9) |
NCL-L-CA19-9 |
C241:5:1:4 |
|
| Sialyl Lewisa (CA19-9) |
PA0424 |
C241:5:1:4 |
|
| SM22 alpha |
NCL-L-SM22a |
10H12 |
|
| SMA (Alpha Smooth Muscle Actin) |
NCL-SMA |
αsm-1 |
|
| SMA (Alpha Smooth Muscle Actin) |
PA0943 |
αsm-1 |
|
| SMA (Alpha Smooth Muscle Actin) |
RTU-SMA |
αsm-1 |
|
| SNAP-25 |
NCL-SNAP-25 |
SP12 |
|
| Spectrin Antibodies |
NCL-SPEC1 |
RBC2/3D5 |
|
| Spectrin Antibodies |
NCL-SPEC2 |
RBC1/5B1 |
|
| Superoxide Dismutase (Cu/Zn) |
NCL-SOD1 |
30F11 |
|
| Surfactant Precursor Protein B |
NCL-SPPB |
19H7 |
|
| Surfactant Protein A |
NCL-SP-A |
32E12 |
|
| Synaptic Vesicle Protein 2 |
NCL-SV2 |
15E11 |
|
| Synaptophysin |
NCL-L-SYNAP-299 |
27G12 |
|
| Synaptophysin |
NCL-SYNAP-299 |
27G12 |
|
| Synaptophysin |
NCL-SYNAPp |
27G12 |
|
| Synaptophysin |
PA0299 |
27G12 |
|
| Synaptophysin |
RTU-SYNAP-299 |
27G12 |
|
| Synuclein, Alpha |
NCL-ASYN |
KM51 |
|
| Synuclein, Alpha |
NCL-L-ASYN |
KM51 |
|
| Synuclein, Gamma |
NCL-L-GSYN |
KC30 |
|
| S-100 |
NCL-L-S100p |
Polyclonal |
|
| S-100 |
NCL-S100 |
S1/61/69 |
|
| S-100 |
NCL-S100p |
Polyclonal |
|
| S-100 |
PA0900 |
- |
|
| S-100 |
RTU-S100p |
Polyclonal |
|
| Tartrate-Resistant Acid Phosphatase (TRAP) |
NCL-TRAP |
26E5 |
|
| Tau |
NCL-Tau-2 |
Tau-2 |
|
| Tenascin C |
NCL-TENAS-C |
49 |
|
| Terminal Deoxynucleotidyl Transferase |
NCL-L-TdT-339 |
SEN28 |
|
| Terminal Deoxynucleotidyl Transferase |
NCL-TdT-339 |
SEN28 |
|
| Terminal Deoxynucleotidyl Transferase |
PA0339 |
SEN28 |
|
| Terminal Deoxynucleotidyl Transferase |
RTU-TdT-339 |
SEN28 |
|
| Thrombomodulin (CD141) |
NCL-CD141 |
15C8 |
|
| Thymus and Activation-Regulated Chemokine |
NCL-TARC |
6SN |
|
| Thyroglobulin |
NCL-L-THY |
1D4 |
|
| Thyroglobulin |
PA0025 |
1D4 |
|
| Thyroid Peroxidase |
NCL-L-TPO |
AC25 |
|
| Thyroid Stimulating Hormone |
NCL-TSH |
QB2/6 |
|
| Thyroid Stimulating Hormone |
PA0776 |
QB2/6 |
|
| Thyroid Stimulating Hormone Receptor |
NCL-TSH-R2 |
4C1/E1/G8 |
|
| Thyroid Transcription Factor-1 |
NCL-L-TTF-1 |
SPT24 |
|
| Thyroid Transcription Factor-1 |
NCL-TTF-1 |
SPT24 |
|
| Thyroid Transcription Factor-1 |
PA0364 |
SPT24 |
|
| Tissue Inhibitor of Matrix Metalloproteinase Antibodies |
NCL-TIMP1-485 |
6F6a |
|
| Tissue Inhibitor of Matrix Metalloproteinase Antibodies |
NCL-TIMP2-487 |
46E5 |
|
| Tissue Inhibitor of Matrix Metalloproteinase Antibodies |
NCL-TIMP3 |
18D12b |
|
| TNFR1-Associated Death Domain Protein |
NCL-TRADD |
18A11 |
|
| TNF-Related Apoptosis-Inducing Ligand (TRAIL) |
NCL-TRAIL |
27B12 |
|
| Topoisomerase II Alpha |
NCL-TOPOIIA |
3F6 |
|
| Topoisomerase I |
NCL-TOPO I |
1D6 |
|
| Toxoplasma gondii P30 Antigen |
NCL-TG |
TP3 |
|
| Transforming Growth Factor Beta |
NCL-TGFB |
TGFB17 |
|
| Transforming Growth Factor Beta Receptor (Type 1) |
NCL-TGFBR1 |
8A11 |
|
| Troponin Antibodies |
NCL-TROPC |
1A2 |
|
| Troponin Antibodies |
NCL-TROPT |
T1/61 |
|
| Tuberin |
NCL-TUBERIN |
3B4 |
|
| Tubulin Beta II |
NCL-TUB-B2 |
KNY-379 |
|
| Tumor Necrosis Factor Receptor-Associated Factor 1 |
NCL-L-TRAF-1 |
7C11 |
|
| Tyrosinase |
NCL-L-TYROS |
T311 |
|
| Tyrosinase |
NCL-TYROS |
T311 |
|
| Tyrosinase |
PA0322 |
T311 |
|
| Tyrosinase |
RTU-TYROS |
T311 |
|
| Tyrosinase-Related Protein-1 |
NCL-TRP-1 |
G3E6 |
|
| Tyrosine Hydroxylase |
NCL-TH |
1B5 |
|
| Ubiquitin |
NCL-UBIQ |
FPM1 |
|
| Ubiquitin |
NCL-UBIQm |
FPM1 |
|
| Utrophin |
NCL-DRP2 |
DRP3/20C5 |
|
| Varicella-zoster virus |
NCL-VZV |
C90.2.8 |
|
| Vascular Endothelial Growth Factor Receptor-3 |
NCL-L-VEGFR-3 |
KLT9 |
|
| Vesicular Monoamine Transporter (VMAT) Antibodies |
NCL-L-VMAT1 |
RMT77 |
|
| Vesicular Monoamine Transporter (VMAT) Antibodies |
NCL-L-VMAT2 |
NN 136 |
|
| VE-Cadherin (CD144) |
NCL-L-VE-Cad |
33E1 |
|
| Villin |
NCL-L-VILLIN |
CWWB1 |
|
| Villin |
NCL-VILLIN |
CWWB1 |
|
| Villin |
PA0106 |
CWWB1 |
|
| Vimentin |
NCL-L-VIM-572 |
SRL33 |
|
| Vimentin |
NCL-L-VIM-V9 |
V9 |
|
| Vimentin |
NCL-VIM |
VIM 3B4 |
|
| Vimentin |
NCL-VIM-V9 |
V9 |
|
| Vimentin |
PA0033 |
- |
|
| Vimentin |
RTU-VIM-V9 |
V9 |
|
| Vinculin |
NCL-VINC |
V284 |
|
| WAF1 Protein (p21, C1P1) |
NCL-L-WAF-1 |
4D10 |
|
| WAF1 Protein (p21, C1P1) |
NCL-WAF-1 |
4D10 |
|
| Wilms' Tumor |
NCL-L-WT1-562 |
WT49 |
|
| Wilms' Tumor |
PA0562 |
WT49 |
|
| Zap-70 |
NCL-L-ZAP-70 |
L453R |
|
| Zap-70 |
PA0998 |
- |
|
